Tetrahydro-spiroindoline-pyrrolopyrrole-triones inhibitors of the NRF2-β-TrCP interaction for use in the treatment of fatty liver disease
US-12590100-B2 · Mar 31, 2026 · US
This page is not indexed by search engines while we improve data quality.
Univ Madrid Autonoma — Physics
Univ Madrid Autonoma holds 7 patents in Physics, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Univ Madrid Autonoma |
| Technology | Physics |
| Patents in slice | 7 |
| Recent patents in slice | 3 |
| First year | 2019 |
| Last year | 2026 |
Representative patents
Notable publications linking Univ Madrid Autonoma to Physics.
In vitro method for identifying thoracic aortic aneurysms (TAA) in a subject
US-12163161-B2 · Dec 10, 2024 · US
In vitro method for identifying thoracic aortic aneurysms (TAA) in a subject
US-12163161-B2 · Dec 10, 2024 · US
In vitro method for identifying thoracic aortic aneurysms (TAA) in a subject
US-12163161-B2 · Dec 10, 2024 · US
Tetrahydro-spiroindoline-pyrrolopyrrole-triones inhibitors of the nrf2-beta-trcp interaction for use in the treatment of fatty liver disease
US-2023348482-A1 · Nov 2, 2023 · US
Recent filings
Latest patents from Univ Madrid Autonoma in Physics.
Tetrahydro-spiroindoline-pyrrolopyrrole-triones inhibitors of the NRF2-β-TrCP interaction for use in the treatment of fatty liver disease
US-12590100-B2 · Mar 31, 2026 · US
In vitro method for identifying thoracic aortic aneurysms (TAA) in a subject
US-12163161-B2 · Dec 10, 2024 · US
In vitro method for identifying thoracic aortic aneurysms (TAA) in a subject
US-12163161-B2 · Dec 10, 2024 · US
In vitro method for identifying thoracic aortic aneurysms (TAA) in a subject
US-12163161-B2 · Dec 10, 2024 · US
Tetrahydro-spiroindoline-pyrrolopyrrole-triones inhibitors of the nrf2-beta-trcp interaction for use in the treatment of fatty liver disease
US-2023348482-A1 · Nov 2, 2023 · US
Related pages
Navigate to parent entity pages.